The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds (Q28143982)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 24 January 2000)

The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds

Language	Label	Description	Also known as
English	The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds	scientific article (publication date: 24 January 2000)	The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds

Statements

scholarly article

0 references

The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds (English)

0 references

The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds (English)

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

author name string

E P Prinssen

1

0 references

W Koek

2

0 references

M S Kleven

3

0 references

Eric P.M Prinssen

1

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

Wouter Koek

2

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

Mark S Kleven

3

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

language of work or name

0 references

publication date

24 January 2000

0 references

January 2000

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

European Journal of Pharmacology

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

388

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

1

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

57-67

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Involvement of 5-HT1C-receptors in drug-induced penile erections in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: A Novel 5-HT2C/5-HT2B Receptor Antagonist with Improved Affinity, Selectivity, and Oral Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Behavioral pharmacology of antagonists at 5-HT2/5-HT1C receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

MCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

D-2 selective receptor antagonists suppress sucrose sham feeding in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900859-6

7 January 2021

Identifiers

10.1016/S0014-2999(99)00859-6

1 reference

DOI.org query endpoint

https://doi.org/10.1016%2FS0014-2999%2899%2900859-6

25 May 2017

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28143982&oldid=1609197643"